|
NAA15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.783800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.285600E-01 |
| Normal-vs-Stage2 |
5.151600E-01 |
| Normal-vs-Stage3 |
4.839000E-01 |
| Normal-vs-Stage4 |
2.249000E-01 |
| Stage1-vs-Stage2 |
2.446000E-01 |
| Stage1-vs-Stage3 |
2.183600E-01 |
| Stage1-vs-Stage4 |
1.221810E-01 |
| Stage2-vs-Stage3 |
9.392800E-01 |
| Stage2-vs-Stage4 |
6.203200E-01 |
| Stage3-vs-Stage4 |
5.364000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.866600E-01 |
| Normal-vs-AfricanAmerican |
8.022400E-01 |
| Normal-vs-Asian |
4.832800E-01 |
| Caucasian-vs-AfricanAmerican |
8.071000E-01 |
| Caucasian-vs-Asian |
6.940600E-01 |
| AfricanAmerican-vs-Asian |
7.434000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.367200E-01 |
| Normal-vs-Female |
1.703510E-02 |
| Male-vs-Female |
5.152400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.173000E-01 |
| Normal-vs-Extreme_Weight |
2.103800E-01 |
| Normal-vs-Obese |
3.659400E-01 |
| Normal-vs-Extreme_Obese |
4.574600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.830000E-01 |
| Normal_Weight-vs-Obese |
1.979200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.870600E-01 |
| Extreme_Weight-vs-Obese |
5.505500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.226800E-01 |
| Obese-vs-Extreme_Obese |
3.909000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.361980E-01 |
| Normal-vs-Age(41-60Yrs) |
3.462200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.685600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.051530E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.303200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.287860E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.413980E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.548000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.337900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.394200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.560600E-01 |
| Normal-VS-Type2 PRCC |
5.272600E-01 |
| Normal-VS-KIRP CIMP |
5.233500E-02 |
| Normal-VS-Unclassified PRCC |
2.971800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.845800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.522100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.643500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.967900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.319020E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.346400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.142300E-02 |
| Normal-vs-N1 |
4.108300E-02 |
| Normal-vs-N2 |
7.077200E-01 |
| N0-vs-N1 |
5.479600E-03 |
| N0-vs-N2 |
2.586400E-01 |
| N1-vs-N2 |
6.377200E-01 |
|
|
